CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance cancer treatment by developing bioartificial extracellular vesicles that can selectively deliver therapeutic nanoparticles to tumors. It seeks to address challenges related to the stability and immune interactions of these vesicles during clinical applications.
In spite of a growing toolbox of therapies, including classical (radiotherapy, chemotherapy or surgery) and emerging (immunotherapy, precision medicine or hormone therapy) treatments, cancer is a multifaceted global health issue that continues to demand new solutions.
The advent of nanotechnology has added nanoparticle (NPs)-based approaches to the available toolbox in cancer therapy.
Indeed, we now have NPs with extraordinary properties, including drug loading, antibody functionalization and re…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
